Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Dec;19(12):1278-1279.
doi: 10.1038/s41590-018-0257-1.

LAG-3: a very singular immune checkpoint

Yuan Lui  1 , Simon J Davis  2   3
Affiliations
Comment

LAG-3: a very singular immune checkpoint

Yuan Lui et al. Nat Immunol. 2018 Dec.
No abstract available

PubMed Disclaimer

Figures

Figure
Figure. LAG-3 binding does not always correlate with MHC II expression.
(a, left panel) LAG-3 fails to bind MHC II expressed by most plasmacytoid DCs but also mature bone-marrow-derived B cells, despite high levels of MHC II expression by these cells. Maruhashi et al. show that this is because LAG-3 does not bind to unstable MHC II/peptide complexes (left panel). (Right panel) IFNγ triggers expression of the transactivator CIITA, which in turn induces DM expression and peptide editing, the formation of stable MHC II/peptide complexes, and LAG-3 binding, whereupon LAG-3 exerts its inhibitory effects. (b) Ribbon diagrams of HLA-DR (PDB: 1DLH) with the CD4 binding-site colored blue and the region influenced by MHC II/peptide complex stability (residues with RMSD >2Å versus the DM-bound DR1 complex) colored yellow. The structure is shown from the point of view of the T-cell receptor (top panel) and from the side (i.e. rotated 90°; bottom panel).
See this image and copyright information in PMC

Comment on

References

    1. Maruhashi, et al. NI. in press.
    1. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, Freeman GJ, Ahmed R. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 2006;439:682–7. - PubMed
    1. Brahmer JR, Drake CG, Wollner I, Powderly JD, Picus J, Sharfman WH, Stankevich E, Pons A, Salay TM, McMiller TL, Gilson MM, et al. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J Clin Oncol. 2010;28:3167–75. - PMC - PubMed
    1. Le Mercier I, Lines JL, Noelle RJ. Beyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint Regulators. Front Immunol. 2015;6:418. - PMC - PubMed
    1. Triebel F, Jitsukawa S, Baixeras E, Roman-Roman S, Genevee C, Viegas-Pequignot E, Hercend T. LAG-3, a novel lymphocyte activation gene closely related to CD4. J Exp Med. 1990;171:1393–405. - PMC - PubMed

MeSH terms

Substances